Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine
REVIEW|Updated:2024-01-23
|
Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine
Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine
MMR2023年10卷第5期 页码:699-725
Affiliations:
1.Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, 3000-548 Coimbra, Portugal
2.REQUIMTE/LAQV, Group of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, 3000-548 Coimbra, Portugal
3.School of Engineering, Macquarie University, Sydney, NSW 2109, Australia
4.Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA 6150, Australia
5.Department of Chemistry, Shahr-e-Qods Branch, Islamic Azad University, Tehran 374-37515, Iran
6.Integrated Composites Laboratory (ICL), Department of Mechanical and Construction Engineering, Northumbria University, Newcastle Upon Tyne NE1 8ST, UK
7.Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University Shanghai Medical College, Shanghai 200032, China
8.Faculdade de Ciências Médicas, NOVA Medical School, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal
9.Centre for Toxicogenomics and Human Health, Genetics, Oncology and Human Toxicology, Faculdade de Ciências Médicas, NOVA Medical School, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal
10.School of Engineering, Institute for Bioengineering, the University of Edinburgh, Edinburgh EH9 3JL, UK
Author bio:
* xdwang@clintranslmed.org;
pooyan.makvandi@ed.ac.uk;
acsantos@ff.uc.pt
Funds:
the Fundação para a Ciência e Tecnologia (FCT)(SFRH/BD/148771/2019;2021.05914.BD;PTDC/BTM-MAT/4738/2020);also from the European Research Council—ERC Starting Grant(848325)
Cite this article as: Lopes D, Lopes J, Pereira-Silva M, Peixoto D, Rabiee N, Veiga F, et al. Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine. Mil Med Res. 2023;10(1):19.
Cite this article as: Lopes D, Lopes J, Pereira-Silva M, Peixoto D, Rabiee N, Veiga F, et al. Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine. Mil Med Res. 2023;10(1):19. DOI: 10.1186/s40779-023-00453-z.
Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine
Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy
Activated Drp1 regulates p62-mediated autophagic flux and aggravates inflammation in cerebral ischemia-reperfusion via the ROS-RIP1/RIP3-exosome axis
基于ANSYS的EP电磁阀静态性能仿真分析
基于图像识别的轮轨冲角测量系统研究
重载列车车辆轮轨作用研究
相关作者
João Conde
Zhan-Hu Guo
Navid Rabiee
Wei-Feng Lin
Guang-Long Ma
Guang-Long Ma
Xue Zeng
Yun-Dong Zhang
相关机构
Centre for Toxicogenomics and Human Health, Genetics, Oncology and Human Toxicology, NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa
NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa
Department of Materials Science and Engineering, Pohang University of Science and Technology (POSTECH), 77 Cheongam-,-gu
Integrated Composites Laboratory (ICL), Department of Mechanical and Construction Engineering, Northumbria University, Newcastle Upon Tyne
Key Laboratory of Bio-Inspired Smart Interfacial Science and Technology of Ministry of Education, School of Chemistry, Beihang University